Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Dive

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
Journal of Proteome Research|August 14, 2019
Identification of a Biomarker Panel for Early Detection of Lung Cancer PatientsBethany Geary, Michael J Walker, Joseph T Snow, et al.
Molecular Cancer Therapeutics|February 22, 2013
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941Christopher Cawthorne, Natalie Burrows, Roben G Gieling, et al.
NPJ Genomic Medicine|June 29, 2018
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary originPedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, et al.
British Journal of Haematology|February 6, 2016
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group studyTim M Illidge, Hayley S McKenzie, Sam Mayes, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2025
Circulating Tumor Cells Shed Shearosome Extracellular Vesicles in Capillary Bifurcations That Activate Endothelial and Immune CellsAngelos Vrynas, Salime Bazban-Shotorbani, Sara Arfan, et al.
Clinical Colorectal Cancer|December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN StudyRosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
The Lancet. Oncology|October 18, 2015
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trialR Paul Symonds, Charlie Gourley, Susan Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local InflammationJorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, et al.
Tumori|April 27, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trialsLuca Agnelli, Andrea Villa, Fouziah Butt, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
Journal of Proteome Research|August 14, 2019
Identification of a Biomarker Panel for Early Detection of Lung Cancer PatientsBethany Geary, Michael J Walker, Joseph T Snow, et al.
Molecular Cancer Therapeutics|February 22, 2013
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941Christopher Cawthorne, Natalie Burrows, Roben G Gieling, et al.
NPJ Genomic Medicine|June 29, 2018
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary originPedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, et al.
British Journal of Haematology|February 6, 2016
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group studyTim M Illidge, Hayley S McKenzie, Sam Mayes, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2025
Circulating Tumor Cells Shed Shearosome Extracellular Vesicles in Capillary Bifurcations That Activate Endothelial and Immune CellsAngelos Vrynas, Salime Bazban-Shotorbani, Sara Arfan, et al.
Clinical Colorectal Cancer|December 13, 2025
Overall Survival for Bevacizumab Therapy in Metastatic Colorectal Cancer: An Updated Analysis of the TRAVASTIN StudyRosie Maye Solomon, Robert D Morgan, Laura Horsley, et al.
The Lancet. Oncology|October 18, 2015
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trialR Paul Symonds, Charlie Gourley, Susan Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local InflammationJorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, et al.
Tumori|April 27, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trialsLuca Agnelli, Andrea Villa, Fouziah Butt, et al.
Pageof 21